Literature DB >> 1721433

FK 506 inhibits the development of transplant arteriosclerosis.

G D Wu1, D V Cramer, F A Chapman, E Cajulis, H K Wang, T E Starzl, L Makowka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721433      PMCID： PMC3005292     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

Authors:  S Thiru; D S Collier; R Calne
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  T Kino; H Hatanaka; M Hashimoto; M Nishiyama; T Goto; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

3.  Improved technique of heart transplantation in rats.

Authors:  K Ono; E S Lindsey
Journal:  J Thorac Cardiovasc Surg       Date:  1969-02       Impact factor: 5.209

4.  Cardiac transplant atherosclerosis.

Authors:  M E Billingham
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

5.  Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response.

Authors:  D V Cramer; F A Chapman; G D Wu; J B Harnaha; S Q Qian; L Makowka
Journal:  Transplantation       Date:  1990-10       Impact factor: 4.939

6.  Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.

Authors:  R H Hruban; W E Beschorner; W A Baumgartner; S M Augustine; H Ren; B A Reitz; G M Hutchins
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

7.  Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis.

Authors:  D V Cramer; G D Wu; F A Chapman; E Cajulis; H K Wang; L Makowka
Journal:  J Heart Lung Transplant       Date:  1992 May-Jun       Impact factor: 10.247

8.  Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.

Authors:  S Z Gao; J S Schroeder; E L Alderman; S A Hunt; H A Valantine; V Wiederhold; E B Stinson
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

9.  Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis.

Authors:  D V Cramer; S Q Qian; J Harnaha; F A Chapman; L W Estes; T E Starzl; L Makowka
Journal:  Transplantation       Date:  1989-03       Impact factor: 4.939
  9 in total
  4 in total

1.  Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

2.  Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.

Authors:  Maha E Houssen; Mona M Haron; Sheren S Metwally; Tarek M Ibrahim
Journal:  J Physiol Biochem       Date:  2010-10-20       Impact factor: 4.158

Review 3.  [Heart transplantation--state of the art today].

Authors:  B M Meiser; W von Scheidt; M Weis; D Böhm; F Kur; J Koglin; H Reichenspurner; P Uberfuhr; B Reichart
Journal:  Herz       Date:  1997-10       Impact factor: 1.443

Review 4.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.